Results 131 to 140 of about 8,463 (257)

Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and <i>in silico</i> therapeutic targeting. [PDF]

Front Cell Neurosci
Abdullah M, Naz A, Reznikov LR, Qureshi JA, Hasnain A, Obaid A, Ali A.   +6 more
europepmc   +1 more source

Quantification of Central Substance P Receptor Occupancy by Aprepitant Using Small Animal Positron Emission Tomography [PDF]

, 2014
Toshiki Endo, Tomoyuki Saijo, Eisuke Haneda, Jun-ichi Maeda, Makoto Tokunaga, M.-R. Zhang, Ayako Kannami, Hidetoshi Asai, Masatoshi Suzuki, Tetsuya Suhara, Makoto Higuchi   +10 more
openalex   +1 more source

Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. [PDF]

J Zhejiang Univ Sci B
Wang Y, Gao J, Cheng Y, Pan H, Tang H, Liu C.   +5 more
europepmc   +1 more source

Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome [PDF]

, 2014
Fernanda Cristofori, Nikhil Thapar, Efstratios Saliakellis, N. Kumaraguru, Mamoun Elawad, Fevronia Kiparissi, Jutta Köglmeier, Paul Andrews, Keith Lindley, Osvaldo Borrelli   +9 more
openalex   +1 more source

Targeting sirtuin 1/nuclear factor erythroid 2-related factor 2/tumor necrosis factor-α pathway to modulate hepatic ischemia reperfusion-induced injury. [PDF]

World J Hepatol
Kelleni MT, Abdelzaher WY, Adly M, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Highly effective use of aprepitant in an adolescent girl with severe cyclic vomiting syndrome

, 2021
Maria Nivatsi, Ilona Aslanidou, Elpis Mantadakis   +2 more
openalex   +2 more sources

RETRACTION: "Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres". [PDF]

Biomed Res Int
Research International B.
europepmc   +1 more source

Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]

Medicine (Baltimore)
Chen F, Cai D, Wen H, Zhang L.
europepmc   +1 more source

Evaluation of Efficacy of Adding Aprepitant to Palonosetron and Dexamethasone in Carboplatin and Etoposide Therapy

Tatsuhiko Sakamoto, Moeko Kado, Yoshitaka Saito, Kazuki Uchiyama, Ryota Kanno, Osamu TANIGUCHI, Yoh Takekuma, Jun Sakakibara‐Konishi, Yasushi Shimizu, Ichiro Kinoshita, Mitsuru Sugawara   +10 more
openalex   +2 more sources

Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]

J Natl Cancer Inst
Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK, Støer NC, Bhargava S, Ursin G, Gandini S, Sloan EK, Chang A.   +10 more
europepmc   +1 more source